Adverum Biotechnologies Inc - Company Profile
Powered by
All the data and insights you need on Adverum Biotechnologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Adverum Biotechnologies Inc Strategy Report
- Understand Adverum Biotechnologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Adverum Biotechnologies Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
01 Mar 2021 | LEXEO Therapeutics Enters into Licensing Agreement with Adverum Biotech | Licensing Agreement |
LEXEO Therapeutics LLC
|
Adverum Biotechnologies Inc |
11 Aug 2020 | Adverum Biotech Raises USD216.8 Million in Public Offering of Shares | Equity Offering | - |
Adverum Biotechnologies Inc |
10 Feb 2020 | Adverum Biotech Raises USD150.2 Million in Public Offering of Shares | Equity Offering | - |
Adverum Biotechnologies Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer